Delivery Order SPE2DB22D1103-SPE2DB25FTKQ6
Award Date
4/18/25
Potential Completion Date
4/21/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DB20D1004|SPE2DB25FNGSP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order with a Firm Fixed Price pricing type, has a ceiling value of $1,214.30 and an ultimate completion date of April 30, 2025. The contract is for the procurement of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product, and does not have a set-aside...
This federal contract award, identified as SPE2DB22D3016|SPE2DB25FANE8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product, with a ceiling value of $2,702.40 and a completion date of February 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This Federal contract award, with ID SPE2DB22D2005|SPE2DB24FJFM1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product, with a ceiling value of $1,126.60. The contract has an ultimate completion date of December 14, 2023 and is a Firm Fixed Price Delivery Order. There was no set-aside designation used for this award. Amerisourcebergen Drug Corp is a major...
This federal contract award, with the ID SPE2DB20D3103|SPE2DB25FM4E8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,405.80 and a period of performance through January 23, 2025. The contract was awarded on January 22, 2025 and does not have a...
This federal contract award, with the ID SPE2DB22D2005|SPE2DB25FJHL5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a medical supply item, with a ceiling value of $10,243.28. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 14, 2025. The contract was...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,044.93, is a Delivery Order for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and an ultimate completion date of December 11, 2024. The award was made on December 10, 2024, and there was no set-aside designation,...
This federal contract award, with ID SPE2DB20D2014|SPE2DB25FB68N, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,757.25 delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This federal contract award, with ID SPE2DB22D3010|SPE2DB25FP2FF, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication, with a ceiling value of $9,358.09. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 21, 2025. The contract is not set aside for any specific type of business. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,405.80, is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 14, 2025. There is no set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award, with ID SPE2DB22D3016|SPE2DB25FAUZ4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,831.62 Firm Fixed Price delivery order is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication. The contract is not set-aside and has an ultimate completion date of April 29, 2025. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit organization based in Conshohocken,...